[Skip to Content]
[Skip to Content Landing]
June 11, 1932


JAMA. 1932;98(24):2150-2151. doi:10.1001/jama.1932.02730500116020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The Control of Pharmaceutic Advertisements  Prof. Marcel Labbé recently brought before the Academy of Medicine a question of great importance. He read a number of advertising leaflets vaunting the merits of a product with a sorbite base, presented to the public as a sugar that has been deprived of all harmful effects for diabetics, whereas, according to Professor Labbé, sorbite is no better tolerated by patients than other carbohydrates. He demands, therefore, that the academy take the initiative in putting the public on its guard against these erroneous statements so harmful to public health, and take a firm stand against the selling with impunity of products likely to be dangerous. French laws are silent on this subject. There is absolutely no control of the value of products advertised to the public, except for serums and vaccines. The law demands only that the exact composition of the product be stated on

First Page Preview View Large
First page PDF preview
First page PDF preview